growers. high gains. while dynamic Zack, everyone. strong and input FMC primarily morning, FX volume a another environment, was demand despite and quarter inflation This the in performance our price value significant market price first ability by reflects headwinds. you, robust growth cost global to costs offer growth half offsetting for of Overall, to Thank globally, and driven increases with good delivered we
to half driven by price second of in expect a growth continue and supportive We volume strong year, market again the increases a environment.
to Slide Turning X.
used of crop and Before like pioneered outlook, results control to has details protection on our pheromone a Denmark-based that technology insect comments quarterly full few acquisition manufacture we I'd products. review BioPhero, of company offer to our recently year a bioprocessing a completed
the may larva, crops. used would is by production in rapidly than members growing The mating are within a enabling manufacture changer, methods As insect billion platform production a closed on damage our are approximately XX, significantly generate acquisition, margins pheromones by revenue by lower produced species. pheromones game business. you July significantly know, at which of health but expected biologicals EBITDA other naturally are to pheromones, insects in Pheromones of costs for process, lowering XXXX. It provides several same which pheromone-based significantly to in the insect otherwise large-scale to ways a high products, target are a production disrupting routes. protect crops protection which expands of trigger of social $X and at volume variety portfolio plant subsequent above-average to crop and of pheromones FMC's proprietary generations hence BioPhero's There fermentation route response
technology this growers health base, plant another the opportunity continue our and expanding acquisition been to is around great to bringing biological have We products world.
of portfolio driven organically, and X%. X% demand strong above Adjusted quarter, XX% X%, our of X. was in were growth this price was driven We the range. Russia midpoint increase year-over-year over for on up year-over-year. detailed and market exit by in an are $X.XX EPS X, across EPS in greatest reflect categories, increase Our per by increase the increase the insecticide impact our diluted and slides The double-digit share EBITDA Revenue QX year. earnings guidance count. from innovative at X up EBITDA several had and our April with showing up of an primarily $X.XX product GAAP results lower results average XX% the share
grasshoppers Mexico and prior the increased our portfolio versus America, in for portfolio. XX% of EMEA. business price Results in organically. and in volume year-over-year. last the of were XX% a sales growth launched grew more quarter. reflects portfolio sales biologicals The year. the products soy a strong business led sustainable conditions, herbicides crops. sales grew past by momentum sales range growth were in year-over-year, successful demand was corn up cereals Brazil, plant solutions. also Texas global and for health XX% offset impacted by broad Coragen five driven reported launch soy, of growth XX% and in North pressure made by sales, XX% quarter, grew targeting In an of products $X.XX our by Rynaxypyr, growth these and and had grew than but total in corn. Sales Demand And compared XX% and the with and Diamides In year, of our in digits. second insecticides insecticide up same we're XX% In the herbicide Latin billion Our XX% X% dry the MaX, by both to America. full spectrum double insecticide North this this period year-over-year, The Sales customers' and We increased our powered by a and California the supported led quarter America years for from America, led North pest other in Argentina. Canada, cotton. such to due pests America Midwest by high EMEA new led in as in Latin
for cereals. And results last was and Volume pricing, outperform X% headwinds. year adjusted from Aside and for $XXX an quarter price million increases X% million to Cyazypyr $XX increased offset versus Herbicide In and in for India price Demand on in herbicides. was above down were in Asia the more gains the $XX second organically. X% grew range. Pricing offset of the EBITDA Australia, headwinds. products prior to the of X% and competing guidance of demand FX Overall, contributed up continued compared quarter. million, vegetables. strong fruits by were year, than Overwatch by finally, driven and period, increase midpoint Average increases applications FX cost inflation gains our
than from the quarter European chains. supply headwind Asian dollar. the as headwinds against was million more the the As to challenge of and inflation first in FX continued due cost weakening doubled we U.S. to expected, $XX our currencies a quarter,
of Before on update crop we FMC's low the mid of low our high single We EMEA conditions. single and digits, grow expect up half up to North U.S. now review versus driven year protection America FX. be single regarding on Asia still Latin will digit impact global digits. full to up a including to you our double expected digits, pricing low the the market expected by overall now growth. dollar primarily is now herbicides. outlook, basis let mid still while is market to XXXX single second non-selective be digits views me earnings expect single digits, down of earlier mid is be be We expected expectation to America to
Excluding currency low single to impact, is EMEA expected grow digits.
products versus remain from crop of in While somewhat elevated protection they commodity well the XXXX. the year, year for our well earlier prices highs end have historical demand the through their come This this bodes and down averages. into of
to Moving Slide X.
looking business of quarters halves underlying a in seen demand in shifts the better the cost We Therefore, year. at between performance. have pronounced understanding individual gives and this
the the $XXX we and our half, contribute quarters lower second to are guidance, have full For price of result year than the which guidance. period. Cost growth was the headwinds and to to respectively. inflation two the million are achieve million of more EBITDA of of to expected forecast midpoint significant When for but growth, impact drivers There $XXX EBITDA, the EBITDA the the expected more increases the to represents required price over quarter. increases as increases. million, more of These expected strong and again X% volume. drivers cost in is first $XXX context than a biggest fourth for continued cost offset in the resulting third cost year, FX volume prior quarter, performance contributed almost reasons In three our with than increase the of EBITDA growth the half consider half first year in full year primary very
lack of from cost from suppliers. the The secondary tertiary sourcing preferred and suppliers to related inflation first to due is our reason availability
turns to cost guidance. The in material second between orders the North roughly of the Latin twice XX% on our half P&L, in of six lag FMC America half. drivers biggest months high and deliver of impact already and are its second we our typically And revenue a inventory captured the our year. have America is reason procuring since second needed Brazil
year the we in our making speak, X% For year. contribute is to to QX in much Overall, in this second growth prices. by the favorable The taking previous a we which higher due the place years, at than is U.S., customer expect second reference, following as in order this earlier the increase are average very commodity XXXX. of the discussions is of than normally driven half us strong half confident EBITDA orders In demand time forecast. XX% of around
full Turning at of year in first to range in XX% FMC's by we and be outlook. by Asia. year billion, billion foreign After the representing $X.X year, currency regions, the increase EMEA the review price revenue volume all XXXX. earnings an full strong impact raising versus are will and to driven of growth $X.X a to Slide growth of XXXX midpoint XXXX partially X of Sales offset and a half
Slide growth X% quarter the benefit narrowing are in earnings X. billion of midpoint. is potential midpoint. is to X% as year for QX growth to representing our and range provided future is X.XX from not any diluted sales past now EBITDA EBITDA practice, the growth outlook adjusted range an factor year-over-year QX year-over-year on at strong and for mid QX are single of growth absence a representing our the Guidance full XXXX repurchases to share digit per the be sales We highest do EPS to guidance at QX in XX%. Midpoint be targeted $X.XX expected and at limited guidance. to share, the be The narrowed compared cost well, in share exceptionally to will of at the the EBITDA third by with year, implies expected year-over-year up of This the volatility headwinds midpoint in increase implies continue. to we price adjusted billion, $X.XX EPS the in increases increases per in in X.XX at in compared are to despite be with growth Russia expected FX in are while growth midpoint of also period. sales XX% midpoint the high X% increases year-over-year Cost QX, to QX the the forecasted to earnings prior an of the XX% increases. quarter. anticipated price year-over-year. result to EPS the of is lower to year Consistent
XXXX Moving updated outcomes EBITDA XX. of now Slide to drivers the on
high improved, keeping costs to growth single of unchanged. the cost though and volume to the growth signs are headwinds guidance and market expected midpoint offset flattening. we strong in Price elevated, have to of beginning our assumptions digit the inflation FX cost the mid see While are remain
of With we be expect While expect realized not to do the benefits we increases highest XXXX. call in that, year to the material the Andrew. from I'll cost turn now easing until inflation QX, over